Document is current

Article History

Accepted: 23 October 2024

First Online: 13 November 2024

Declarations

:

: No external funding was used in the preparation of this manuscript. EUSP Scholarship from the European Association of Urology (PR).

: T.Kimura is a paid consultant/advisor for Astellas, Bayer, Janssen, and Sanofi. S.F.S. received honoraria from Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Roche, and Takeda; Performed a consulting or advisory role for Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Pierre Fabre, Roche, and Takeda; and speaker bureau for Astellas, Astra Zeneca, Bayer, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Richard Wolf, Roche, and Takeda. T.Y., K.M., A.M., T.Kawada, S.K., E.L., P.R., F.Q., B.P., W.F., K.I., L.A., G.M., L.S.M., A.G., K.H.T., J.C.-V., J.D.S., Y.A.G., E.G.-J., F.D.G., R.P., J.Y.-C.T., M.M., W.K., and J.M. declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.

: Not applicable.

: Not applicable.

: Not applicable.

: The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.

: Not applicable.

: T.Y. and K.M. contributed to the protocol/project development, data collection and management, data analysis, and manuscript writing/editing; A.M., T. Kawada, and S.K. contributed to the data analysis and manuscript writing/editing; E.L., P.R., F.Q., B.P., W.F., K.I., L.A., G.M., L.S.M., A.G., K.H.T., J.C.-V., J.D.S., Y.A.G., E.G.J., F.D.G., R.P., J.Y.-C.T., M.M., W.K., and J.M. contributed to the manuscript writing and editing; S.F.S. and T. Kimura contributed to manuscript editing and supervision. All authors read and approved the final manuscript.